Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
CME/CPD
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
CME/CPD
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
BARRETT'S CARCINOMA
Email alerts
BARRETT'S CARCINOMA
Endoscopic management of Barrett's and early oesophageal neoplasia
G
Lipman
,
RJ
Haidry
Frontline Gastroenterology
Apr 2017,
8
(2)
138-142;
DOI:
10.1136/flgastro-2016-100763
Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett's oesophagus and confirmed low-grade dysplasia
Philip
Hendy
Frontline Gastroenterology
Jul 2016,
7
(3)
156-157;
DOI:
10.1136/flgastro-2015-100649
Endoscopic resection for oesophageal mucosal adenocarcinoma
Philip
Hendy
Frontline Gastroenterology
Jul 2014,
5
(3)
154;
DOI:
10.1136/flgastro-2014-100450
Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience
J
Ortiz-Fernández-Sordo
,
S
Sami
,
R
Mansilla-Vivar
,
J
De Caestecker
,
A
Cole
,
K
Ragunath
Frontline Gastroenterology
Jan 2016,
7
(1)
24-29;
DOI:
10.1136/flgastro-2015-100561
The new treatment paradigm for Barrett's dysplasia
Laurence
Lovat
Frontline Gastroenterology
Jan 2016,
7
(1)
30-31;
DOI:
10.1136/flgastro-2015-100584
CLINICAL
Evidence based practice
Guidelines
Gastroenterology
Drugs: gastrointestinal system
Endoscopy
GI bleeding
Angiodysplasia
Neoplasms
Ulcer
Varices
Infection
Campylobacter, Salmonella, Shigella, Escherichia coli
Clostridium difficile
Gastroenteritis
Giardiasis
Helicobacter pylori
Parastic worms
Inflammatory bowel disease
Crohn's disease
Ulcerative colitis
Liver disease
Alcoholic liver disease
Cirrhosis
Hepatitis B
Hepatitis C
Hepatitis other
Nonalcoholic steatosis
Neurogastroenterology
Chronic intestinal pseudo-obstruction
Constipation
Diarrhoea
Dyspepsia
Gastric emptying disorders
Irritable bowel syndrome
Oesophageal dysmotility
Oesophagus
Gastro-oesophageal reflux
Pancreas and biliary tract
Pancreatitis
Small intestine
Coeliac disease
Gastrointestinal hormones
Malabsorption
Stomach and duodenum
Infectious diseases
Oncology
Colon cancer
Gastric cancer
Hepatic cancer
Intestinal cancer
Oesophageal cancer
Pancreatic cancer
Special collections
Editor's choice
(31)
Guidelines, Recommendations and Consensus Statements
GUT Snapshot
Open access
(89)
Press releases
Therapeutic Monitoring
(4)
